Investigating whether individuals with naturally switched-off GPX1P1 and CYP4F24P are at a higher risk of nasopharyngeal cancer will enable genotyping to identify individuals at elevated risk for nasopharyngeal cancer, facilitating early interventions and improving patient outcomes. This evidence concerns the gene CYP4F24P and nasopharyngeal carcinoma.